700 million yuan, step by step research on new varieties of biological drugs
-
Last Update: 2019-01-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On January 5, step pharmaceutical released a notice that its wholly-owned subsidiary, Shandong Danhong, had recently received the notice on the second batch of projects for the 2018 implementation plan of major science and technology projects of "major new drug creation" issued by the medical and health science and technology development research center of the national health and family Planning Commission (h.k.h [2018] No 676) The project "recombinant new protein drugs and gene therapy, research and development of new varieties of nucleic acid drugs and key innovative technologies" (Project No.: 2018zx09733001) was supported The responsible unit of the project is Sichuan University, with 23 pharmaceutical enterprises and academic institutions including Shandong Danhong, jiannenglong Pharmaceutical Technology (Shanghai), Chengdu Kanghong and Rongchang biopharmaceutical (Yantai) The total funding of the project is 726 million yuan The specific announcement is as follows:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
